Clinical trial
EXercise As an Anti-inflammatory Treatment in Axial Spondyloarthritis (axSpA) for Patients Taking Biologic Therapy: a Proof of Concept Study (ExTASI-B).
NCT06669702 is registered in ClinicalTrials.gov with Loughborough University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EXercise As an Anti-inflammatory Treatment in Axial Spondyloarthritis (axSpA) for Patients Taking Biologic Therapy: a Proof of Concept Study (ExTASI-B).
- Lead sponsor
- Loughborough University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- July 31, 2029
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, axial spondyloarthrithis, inflammatory diseases